Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment

INTRODUCTION: Risk of herpes zoster (HZ) is increased with Janus kinase inhibitor use. We evaluated clinical study data relating to HZ management in patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) receiving tofacitinib. METHODS: This post hoc analysis included data from 21 RA an...

Descripción completa

Detalles Bibliográficos
Autores principales: Winthrop, Kevin L., Curtis, Jeffrey R., Yamaoka, Kunihiro, Lee, Eun Bong, Hirose, Tomohiro, Rivas, Jose L., Kwok, Kenneth, Burmester, Gerd R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814083/
https://www.ncbi.nlm.nih.gov/pubmed/34870800
http://dx.doi.org/10.1007/s40744-021-00390-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814083/
https://www.ncbi.nlm.nih.gov/pubmed/34870800
http://dx.doi.org/10.1007/s40744-021-00390-0

Ejemplares similares